NCT03657641

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2019-06-21Est. Completion: 2023-02-27

Enrollment target: 73 participants

Locations

City of Hope, Duarte, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Moffitt Cancer Center, Tampa, Florida, United States

Metastatic Colorectal CancerCRCKRAS/NRAS Mutation

The purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effe…

Phoenix, United StatesEst. completion Nov 2026

Rectal Cancer PatientsRobotic Assisted Intervention

TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with pot…

Guangzhou, ChinaEst. completion Apr 28, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.